These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11510626)

  • 1. Morphine-6-glucuronide: an analgesic of the future?
    Lötsch J; Geisslinger G
    Clin Pharmacokinet; 2001; 40(7):485-99. PubMed ID: 11510626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
    Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
    Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
    Frances B; Gout R; Monsarrat B; Cros J; Zajac JM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine metabolites.
    Christrup LL
    Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral opioid analgesia in experimental human pain models.
    Tegeder I; Meier S; Burian M; Schmidt H; Geisslinger G; Lötsch J
    Brain; 2003 May; 126(Pt 5):1092-102. PubMed ID: 12690049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Noninvasive Brain-Penetrating Peptide-Drug Conjugate Strategy to Improve the Delivery of Opioid Pain Relief Medications to the Brain.
    Eiselt É; Otis V; Belleville K; Yang G; Larocque A; Régina A; Demeule M; Sarret P; Gendron L
    J Pharmacol Exp Ther; 2020 Jul; 374(1):52-61. PubMed ID: 32327529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-6-glucuronide: morphine's successor for postoperative pain relief?
    van Dorp EL; Romberg R; Sarton E; Bovill JG; Dahan A
    Anesth Analg; 2006 Jun; 102(6):1789-97. PubMed ID: 16717327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
    Stain F; Barjavel MJ; Sandouk P; Plotkine M; Scherrmann JM; Bhargava HN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):852-7. PubMed ID: 7636748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.
    Lötsch J; Skarke C; Schmidt H; Grösch S; Geisslinger G
    Anesthesiology; 2001 Dec; 95(6):1329-38. PubMed ID: 11748388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-6-glucuronide contributes to rewarding effects of opiates.
    Abbott FV; Franklin KB
    Life Sci; 1991; 48(12):1157-63. PubMed ID: 2002747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.
    Wu D; Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1997 Jun; 25(6):768-71. PubMed ID: 9193881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of analogues of M6G.
    Trécant C; Dlubala A; George P; Pichat P; Ripoche I; Troin Y
    Eur J Med Chem; 2011 Sep; 46(9):4035-41. PubMed ID: 21689868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
    Murthy BR; Pollack GM; Brouwer KL
    J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
    Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G
    Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients.
    Ihmsen H; Schüttler J; Jeleazcov C
    Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):249-263. PubMed ID: 33547559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 12-oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6-glucuronide in Wistar rats.
    Yang L; Fawcett JP; Zhang H; Tucker IG
    J Pharm Pharmacol; 2013 Apr; 65(4):561-6. PubMed ID: 23488785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
    Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
    Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.
    Abbott FV; Palmour RM
    Life Sci; 1988; 43(21):1685-95. PubMed ID: 2848167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.